Cart
sales@molnova.com
Flecainide hydrochloride
CAS No. 57415-44-8
Flecainide hydrochloride( —— )
Catalog No. M22227 CAS No. 57415-44-8
Flecainide is a medication used to prevent and treat abnormally fast heart rates. This includes ventricular and supraventricular tachycardias.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 154 | In Stock |
|
| 50MG | 221 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFlecainide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionFlecainide is a medication used to prevent and treat abnormally fast heart rates. This includes ventricular and supraventricular tachycardias.
-
DescriptionFlecainide is a medication used to prevent and treat abnormally fast heart rates. This includes ventricular and supraventricular tachycardias.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number57415-44-8
-
Formula Weight450.8
-
Molecular FormulaC17H21ClF6N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (554.57 mM)
-
SMILES[F]C([F])([F])COc1ccc(OCC([F])([F])[F])c(c1)C(=O)NC[C@@]2([H])CCCCN2.[Cl]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Markey, Gerard, C, et al. INTRAVENOUS FLECAINIDE FOR EMERGENCY DEPARTMENT MANAGEMENT OF ACUTE ATRIAL FIBRILLATION[J]. Journal of Emergency Medicine, 2018.
molnova catalog
related products
-
6-Malonylthymosin I
Kaempferol 3-O-(2′′-O-α-rhamnosyl-6′′-O-malonyl-β-glucoside) is a flavonoid glycoside compound.
-
Isoanhydroicaritin
Isoanhydroicaritin is a flavonoid isolated from the dried root of S. flavescens.
-
Fz7-21
Fz7-21 is a peptide antagonist of FZD7 . It antagonises WNT3A-induced Wnt-β-catenin signalling in HEK293 expressing FZD7. Fz7-21 impairs Wnt/β-catenin signaling in HEK293 cells stimulated with exogenous WNT3A (IC50=100?nM) or transfected with a construct expressing WNT3A or WNT1. Fz7-21 also blocks WNT3A-mediated stabilization of β-catenin in mouse L cells (IC50=50?nM).
